+46 70 355 57 56 Word count (text only): 3010 Display items: 1 Table, 4 figures, 12 eFigures, 7 eTables References: 55Running Title: Neonatal acute phase proteins and autism spectrum disorders Abstract Background: Immune signaling pathways influence neurodevelopment and are hypothesized to contribute to the etiology of autism spectrum disorders (ASD). We aimed to assess risk of ASD in relation to levels of neonatal acute phase proteins, key components of innate immune function, measured in neonatal dried blood spots.Method: We included 924 ASD cases, 1092 unaffected population-based controls, and 203 unaffected siblings to ASD cases in this case-control study nested within the register-based Stockholm Youth Cohort. Concentrations of nine different acute phase proteins were measured in eluates from neonatal dried blood spots from cases, controls, and siblings using a bead-based multiplex assay.Results: C reactive protein was consistently associated with odds of ASD in case-control comparisons, with higher odds associated with the highest quintile compared to the middle quintile (OR 1.50, 95% CI 1.10 -2.04) in adjusted analyses. In contrast, the lowest quintiles of alpha-2-macroglobulin (3.71, 1.21 -11.33), ferritin (4.20, 1.40 -12.65), and Serum Amyloid P (3.05, 1.16 -8.01) were associated with odds of ASD in the matched sibling comparison. Neonatal acute phase proteins varied with perinatal environmental factors and maternal/fetal phenotypes. Significant interactions in terms of risk for ASD were observed between neonatal acute phase proteins and maternal infection in late pregnancy, maternal anemia, and maternal psychiatric history.Conclusions: Indicators of the neonatal innate immune response are associated with risk for ASD, though the nature of these associations varies considerably with factors in the perinatal environment and the genetic background of the comparison group.We implemented a case-finding procedure covering all pathways to child and adolescent psychiatric care and habilitation services in Stockholm County (20,21). Ascertainment of ASD, ID, and ADHD in the SYC is described in Table S1. The outcome of ASD was stratified by presence of co-occurring ADHD and ID: ASD with ID, ASD with ADHD, and ASD without ID or ADHD (ASD only). Individuals diagnosed with both co-occurring ID and ADHD (n=111) were included in the ASD with ID group.
Laboratory analysisNeonatal dried blood spots (NDBS) were collected from the national biobank at Karolinska University Hospital, Solna. Blood spots were originally collected at approximately 3-5 days after birth (mean=4.1 days, SD=1.3). We selected a smaller sample (born 1998-2000) of the NDBS collected for analysis of immune markers. A sample (12.5 %) of those born 1996-1997 was also included. Our final sample consisted of 924 ASD cases and 1092 controls, as well as 203 unaffected siblings to ASD cases ( Figure S1).A 3.2 mm diameter disc was punched from each NDBS, immersed in 200 μL of phosphate buffered saline, and incubated at room temperature on a rotary shaker (600...